Skip to main content

Table 1 Baseline characteristics

From: Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)

Characteristic

Overall

(N = 849)

MetS+

(n = 213)

MetS-

(n = 368)

p-Value

(+ vs -)

  

Mean ± SD

  

Mean age, yrs (range)

52.1 ± 12.3

(20-85)

(n = 845)

53.0 ± 11.3

(21-83)

(n = 212)

50.9 ± 12.2

(24-85)

(n = 367)

0.04

Hip circumference, cm [inches]

106.4 ± 14.7 [41.9 ± 5.8]

(n = 836)

114.0 ± 15.0 [44.9 ± 5.9]

(n = 212)

100.1 ± 12.2 [39.4 ± 4.8]

(n = 364)

<0.0001

BMI, kg/m2

31.4 ± 6.9

(n = 846)

34.6 ± 6.6

(n = 213)

28.7 ± 6.4

(n = 368)

<0.0001

Waist circumference, cm [inches]

103.9 ± 16.5 [40.9 ± 6.5]

(n = 835)

114.3 ± 16.0 [45.0 ± 6.3]

(n = 211)

95.5 ± 13.7 [37.6 ± 5.4]

(n = 363)

<0.0001

Fasting blood glucose, mg/dL [mmol/L]

106.4 ± 36.6

[5.9 ± 2.0]

(n = 455)

118.3 ± 40.0

[6.6 ± 2.2]

(n = 189)

96.6 ± 31.2

[5.4 ± 1.7]

(n = 244)

<0.0001

Systolic BP, mmHg

129.2 ± 15.3

(n = 845)

134.3 ± 15.8

(n = 213)

122.8 ± 12.9

(n = 364)

<0.0001

Diastolic BP, mmHg

79.5 ± 9.5

(n = 845)

82.5 ± 9.6

(n = 213)

76.1 ± 8.3

(n = 365)

<0.0001

HDL cholesterol, mg/dL

[mmol/L]

43.3 ± 12.6

[1.1 ± 0.3]

(n = 468)

38.1 ± 9.6

[1.0 ± 0.2]

(n = 203)

47.8 ± 12.8

[1.3 ± 0.3]

(n = 241)

<0.0001

LDL cholesterol, mg/dL

[mmol/L]

104.3 ± 37.9

[2.7 ± 1.0]

(n = 456)

99.7 ± 36.1

[2.6 ± 0.9]

(n = 196)

107.3 ± 37.7

[2.8 ± 1.0]

(n = 235)

0.04

Total cholesterol, mg/dL

[mmol/L]

182.7 ± 45.4

[4.7 ± 1.2]

(n = 472)

179.7 ± 45.5

[4.66 ± 1.2]

(n = 205)

183.4 ± 43.5

[4.8 ± 1.1]

(n = 241)

0.4

Plasma triglycerides, mg/dL

[mmol/L]

175.8 ± 121.1

[2.0 ± 1.4]

(n = 474)

212.1 ± 134.3

[2.4 ± 1.5]

(n = 208)

141.4 ± 94.9

[1.6 ± 1.1]

(n = 239)

<0.0001

  1. Abbreviations: BMI = body mass index; BP = blood pressure; HDL = high-density lipoprotein; LDL = low-density lipoprotein; MetS = metabolic syndrome.